Skip to main content
Top

Supportive Care in Cancer

Issue 2/1999

Content (12 Articles)

EDITORIAL

How about trying even harder...?

H.-J. Senn

SUPPORTIVE CARE INTERNATIONAL

The development for the Japanese Society for Palliative Medicine

Kunihiko Ishitani

SPECIAL ARTICLE

Assessment of the quality of life of patients with advanced and end-stage cancer or serious infections with a symptom-based or an impact-based instrument

P. O. Witteveen, H. M. Jacobs, M. A. C. van Groenestijn, A. C. Lodder, A.H. van Boxtel, M. Nieuwland, M. W. M. Post, F. W. M. M. Touw-Otten, G. H. Blijham

ORIGINAL ARTICLE

The anti-emetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation

Vassilis Barbounis, George Koumakis, Helen Hatzichristou, Michael Vassilomanolakis, Sofocles Tsoussis, A. Efremidis

ORIGINAL ARTICLE

Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride

N. Sohara, Hitoshi Takagi, Takehiko Abe, Yoshiaki Hashimoto, Akira Kojima, Hitomi Takahashi, Takeaki Nagamine, Masatomo Mori

ORIGINAL ARTICLE

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients

J.-P. Marie, Zora Marjanovic, Anne Vekhoff, Anne Bouvet, François Chast, Vincent Levy, Marion Baudard, Ollivier Legrand, Bernard Rio, Alain Delmer, Robert Zittoun

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine